期刊文献+

促心肌素1-C端肽干预大鼠心肌缺血再灌注损伤的效果 被引量:3

Effects of cardiotrophin 1 C-terminal peptides on rats following myocardial ischemia reperfusion injury
下载PDF
导出
摘要 目的观察不同的促心肌素1-C端肽(cardiotrophin-1 C-terminal peptides,CT1C)对大鼠心肌缺血再灌注损伤后组织损伤程度的影响。方法用结扎-松解大鼠冠状动脉左后降支制作模型。正常组5鼠;缺血与再灌注组6鼠,缺血30 min后开始再灌注;缺血与再灌注后干预组8鼠,缺血30 min后开始再灌注,并腹腔注射CT1C-100μg/kg;缺血与再灌注前干预组8鼠,腹腔注射CT1C 100μg/kg,7 d后进行缺血与再灌注。实验结束前取血检测血浆一氧化氮、血清肌酸激酶和丙二醛。结果缺血与再灌注后,大鼠血一氧化氮降低(q=8.758,P<0.01),血肌酸激酶(q=14.391,P<0.01)和丙二醛浓度升高(q=11.015,P<0.01);缺血与再灌注后干预,大鼠血浆一氧化氮升高(q=14.197,P<0.01),清肌酸激酶(q=10.649,P<0.01)和丙二醛降低(q=6.167,P<0.01),但仍高于正常组(P<0.01);缺血与再灌注前干预,大鼠血浆一氧化氮浓度高于正常组(q=9.595,P<0.01),但低于后干预组(q=6.147,P<0.01),血清肌酸激酶(q=6.147,P<0.01)和丙二醛(q=10.551,P<0.01)则高于缺血与再灌注组。结论CT1C再灌注早期短期作用能减轻心肌组织损伤及氧化损伤的程度;但使用较长时间后,大鼠对缺血与再灌注的耐受力降低,组织损伤及氧化损伤的程度明显加重。 Objectives To observe the effect of cardiotrophin 1 C-terminal polypeptides (CTIC) administered pre- and post-ischemia on myocardial injury and oxidative injury after acute ischemia reperfusion in SD rats. Methods The ischemia reperfusion heart model was established by ligating/loosening the left posterior decending branch of coronary artery. Methods pairs of rats were treated with CT1 C-terminal polypeptides either before or after myocardial ischemia, and the plasma NO content and the serum CK activity and MDA content were examined. Results The plasma NO content were decreased and the serum CK activity and MDA content were increased significantly in the ischemia reperfusion group (P〈 0.01 ), on the contrary, the plasma NO content were increased and the serum CK activity and MDA content were decreased significantly in the and post-ischemia group (P〈 0.01). Though the serum CK activity and MDA content were more higher in pre-ischemia group than that in the ischemia reperfusion group (P 〈 0.01 ), the plasma NO were higher than the latter, but lower than that in the post-ischemia group (P〈 0.01). Conclusions The results suggested that the CTIC can exert myocardial protection and antioxidative ability administered after myocardial ischemia, but impair the endurance of cardioamyocytes against ischemia reperfusion injury when CTIC was used long time.
出处 《岭南心血管病杂志》 2008年第3期211-214,共4页 South China Journal of Cardiovascular Diseases
基金 海南省自然科学基金2002年资助课题(30214)
关键词 促心肌素1-C端肽 缺血再灌注损伤 一氧化氮 肌酸激酶 丙二醛 Carditrophin 1 C-terminal polypeptides Ischemia reperfusion injury Nitric oxide Creatine kinase Malondialdehyde
  • 相关文献

参考文献11

  • 1WOLLERT K C, CHIEN K R. Cardiotrophin-1 and the role of gp130-dependent signaling pathways in cardiac growth and development[J]. J Mol Med, 1997, 75 (7): 492-501.
  • 2SHENG Z, KNOWLFON K, CHEN J, et al. Cardiotrophin- 1 (CT-1) inhibition of cardiac myocyte apoptosis via a mitogen-activated protein kinase-dependent pathway. JBC, 1997, 272 (9): 5783-5791.
  • 3KUWAHARA K. SAITO Y, KISHIMOTO I. et al. Cardiotrophin-1 phosphorylates Akt and BAD, and prolongs cell survival via a P13K-dependent pathway in cardiac myocytes [J]. J Mol Cardiol, 2000, 32 (8): 1385-1394.
  • 4MURRY C E, RICHARD V J, REIMER K A, et al.Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode [J].Circ Res, 1990, 66 (4): 913-931.
  • 5ZHAO Z Q, CORVERA J S, HALKOS M E, et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: Comparison with ischemic preconditioning [J]. Am J Circ Physiol, 2003, 285 (254-2) : H579- H588.
  • 6STAAT P, RIOUFOL G, PIOT C, et al. Postconditioning the human heart[J]. Circulation, 2005, 112 (14) : 2143- 2148.
  • 7KIN H, ZHAO Z Q, SUN H Y, et al. Postconditioning attenuates myocardial ischemia-reperfusion injury by inhibiting events in the early minutes of reperfusion[J]. Cardiovasc Res, 2004, 62 (1): 74-85.
  • 8SUN H Y, WANG N P, KERENDI F, et al. Hypoxic postconditioning reduces cardiomyocyte loss by inhibiting ROS generation intracellular Ca overload [J]. Am J Physiol Heart Circ Physiol, 2002, 279: (1) H388-H396.
  • 9陈淑芬,姚震.CT-1对心血管系统的生物学效应与心脏重塑的关系[J].岭南心血管病杂志,2004,10(3):222-225. 被引量:4
  • 10GHOSH S, NG L L, TALWAR S, et al. Cardiotrophin-1 protects the human myocardium from ischemic injury. Comparison with the first and second window of protection by ischemic preconditioning[ J ]. Cardiovasc Res, 2000, 48 (3) : 440-447.

二级参考文献25

  • 1Pennica D, King KL, Shaw KJ, et al.Proc Natl Acad Sci USA, 1995, 92(4):1142- 1146
  • 2Pennica D, Swanso TA, Shaw K J, et al. Cytokine, 1996, 8(3):183 - 189
  • 3Wollert KC, Taya T, Saito M, et al. J Biol Chem, 1996, 271 (16): 9535 -9545
  • 4Robledo O, Fourcin M, Chevalier S.et al. J Biol Chem, 1997, 272 (8):4855 - 4863
  • 5Plun-Faweau H, Perret D, Divan C, et al. J Biol Chem, 2003, 278(29):27169 - 27179
  • 6Wollert KC, Chien KR, J Mol Med,1997, 75(7) :492 - 501
  • 7Sheng Z, Knowlton K, Chen J, et al.J Biol Chem, 1997, 272(9): 5783 -5791
  • 8Kuwahara K, Saito Y, Kishimoto I, et al. J Mol Cell Cardiol, 2000, 38 (8):1385 - 1394
  • 9Brar BK, Stephanou A, Pennica D, et al. Cytokine, 2001, 16 (3):93-96.
  • 10Sheng Z, Penmca D, Wood WI, et al. Development, 1996, 122 (2):419 - 428

共引文献3

同被引文献10

  • 1Sudip Ghosh, Leong LNg, Suneel Talwar, et al. Cardiotrophin 1 protects the human myocardium from ischemic injury [J]. Cardiovascular Research, 2000, 48 (3) :440-447.
  • 2Braunwald E, Antman EM, Beasley JW, et al. ACC/ AHA guideline update for the management of patients with unstable angina and non ST-segment elevation myocardial infarction-2002: Summary article [J]. Am Coll Cardiol,2002,106..1 893-1 900.
  • 3Thygesen K, Alpert JS, white HD, et al. Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction[J]. Eur Heart, 2007, 28(20):2 525-2 538.
  • 4Freed DH, Cunnington RH, Dangerfield AL, et al. Emerging evidence for the role of cardiotrophin-1 in cardiac repair in the infarcted heart[J]. Cardiovasc Res, 2005,65 (4) :782-792.
  • 5Begona Lopez, Jose Mhypertension, Arantxa Gonzalez, et al. Association of Increased Plasma Cardiotrophin-1 With Inappropriate Left Ventricular Mass in Essential Hypertension[J] Hypertension, 2008,51 (2) : e8-9.
  • 6Lopez B, Castellano JM, Gonzalez A, et al. Is plasma cardiotrophin-1 a marker of hypertensive Heart disease [J]. HYPERTENS,2005,23(3): 625-632.
  • 7Talwar S, Squire IB, O'Brien RJ, et al. Plasma cardiotrophin-1 following acute myocardial infarction: relationship with left ventricular systolic dysfunction[J]. Clinical Science,2002,102(1) :9-14.
  • 8Michael Fritzenwanger,Katharina Meusel, Martin Foerster,et al. Cardiotrophin-1 induces interleukin-6 synthesis in human umbilical vein endothelial cells[J]. , 2006,36 : 101-106.
  • 9Asai S, Saito Y, Kuwahara K, et al. The heart is a source of circulating cardiotrophin-1 in humans [J]. Biochem Biophys Res Commun, 2000,279 (2) : 320-323.
  • 10陈淑芬,姚震,张晓芳.CT-1C-末端多肽对大鼠心肌缺血后再灌注心电图的影响[J].临床心电学杂志,2008,17(6):442-445. 被引量:1

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部